FDA Investigator Thomas J Mooney
Thomas J Mooney has inspections in 1 countries as of 31 Oct 2023. Thomas J Mooney has collaborated with a combinined 2544 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
175
Last Inspection Date:
31 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alice S Tsao,
Althea A Williams,
Amatul H Marium,
Amber D Brodas,
Amy W Mai,
Amy W Yan Mai,
Andrew F Cohen,
Andrew J Garufi,
Andrew M Abramowitz,
Ann B Okon,
Ann M Stewart,
Arduino Frankovic,
Arthur G Hurst,
Avital A Shimanovich,
Betty M Ng Lee,
Bijoy Panicker,
Brandy N Lepage,
Brian M Brodman,
Brian S Keefer,
Carr,
Carrie E Jolly,
Cary Greene,
Charanjeet Jassal,
Charisse K Green,
Christian Parra,
Christine M Rivera,
Christopher S Fields,
Daniel L Zheng,
Daniel T Lee,
Daniel W Johnson,
Danna E Solorzano,
Dave M Deroche,
David R Delucia,
Deborah J Parris,
Demitria J Xiradakis,
Dilijeta Bajrami,
Dipesh K Shah,
Donald J Ullstrom,
Dongping Dai, PhD,
Dr. Robert C Horan, MD,
Edmund F Mrak, Jr,
Edouard Viard,
Eric J Reisenauer,
Erica B Raphael,
Erik W Koester,
Evelyn Taha,
Felix Maldonado,
Frank Verni,
Gam S Zamil,
Gary J Lehr,
Gary T Greco,
Gray,
Gregson A Joseph,
Guerlain Ulysse,
Helen B Ricalde,
Ilana Zigelman,
Iram R Hassan, PhD,
Jacqueline S Warner,
James A Liubicich,
Jana J Lau,
Jane Chen,
Jason D Tenney,
Jay T Wong,
Jazmine N Brown,
Jazmine N Still,
Jeffrey J Thibodeau,
Jogy George,
Jose O Hernandez,
Jose Ohernandez Guzman,
Joseph Duca,
Joseph Maselli,
Joseph Milcetic,
Joy P Matthias,
Juan Rjimenez Garcia,
Juanita P Versace,
Judy Friedman,
Juliana Falla,
Justin A Boyd,
Karen L Kosar,
Karishma G Gopaul,
Kenneth H Williams,
Kevin A Gonzalez,
Kimberley A Ricketts,
Kimberly Y Smithson,
Kwong Lee,
Kwong P Lee,
Lawrence W Farina,
Marie Bbuen Bigornia,
Melissa N Gregorio,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael G Sinkevich,
Michael R Dominick,
Mindy M Chou,
Nada F Agabani,
Nariman Patenaude,
Nazmul Hassan,
Neil J Bonzagni, PhD MPH,
Nerizza B Guerin,
Nicole Vaught,
Otto D Vitillo,
Parul M Patel,
Patrick C Klotzbuecher,
Paul E Stein,
Paul Mouris,
Perez,
Peter Abel,
Peter M Trunk,
Peter R Caparelli,
Philip F Istafanos, DMV, MS,
Phyllis J Wilson,
Rachael A Moliver,
Raymond M Lam,
Robert C Howard,
Robert C Steyert,
Robert E Moncayo,
Robert J Veitch,
Ronald Ifraimov,
Samina S Khan,
Samuel T Walker,
Sarah A Meehan,
Sarah A Wangseng,
Satheesh Thomas,
Shantelle I Hughes,
Shari L Kahn,
Shreya Shah,
Simone E Pitts,
Smith,
Sony Mathews,
Sou Chan Chang,
State Agency,
Stephanie T Durso,
Steven M Weinman,
Sunita Vij,
Susan M Joseph,
Susant Hadman,
Syeda N Mahazabin,
Tanya R Syffrard,
Tara K Normandin,
Terry Bridgewater,
Thomas E Friel,
Thomas J Mccrey,
Tiffany S Allison,
Tracy M Portelli,
Uduak M Inokon,
Valerie A Potopsingh,
Wai H Lam,
Wayne J Meyer,
Wayne S Fortenberry,
Yuyan Liang,
Yvonne M Santiago
Thomas J Mooney's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2004 | EIR | NBTY Inc. - EIR, 2004-02-17 |
| February, 2009 | EIR | Gemini Pharmaceuticals, Inc. dba Plus Pharma - EIR, 2009-02-05 |
| April, 2000 | EIR | NBTY, Inc. - EIR, 2000-04-06 |
| October, 2003 | EIR | Amneal Pharmaceuticals of New York, LLC - EIR, 2003-10-10 |
| July, 2006 | EIR | Advance Pharmaceutical, Inc. - EIR, 2006-07-26 |
| January, 2003 | EIR | Corwood Labs Inc - EIR, 2003-01-29 |
| September, 2003 | FDA 483 | PDK Labs, Inc - Form 483, 2003-09-22 |
| May, 2003 | EIR | Contract Pharmacal Corporation - EIR, 2003-05-08 |
| February, 2006 | EIR | LNK International, Inc. - EIR, 2006-02-16 |
| July, 2002 | FDA 483 | Altaire Pharmaceuticals Inc. - Form 483, 2002-07-25 |
| February, 2006 | EIR | LNK International, Inc. - EIR, 2006-08-30 |
| March, 2007 | FDA 483 | Pharbest Pharmaceuticals, Inc. - Form 483, 2007-03-08 |
| February, 2006 | FDA 483 | LNK International, Inc. - Form 483, 2006-02-16 |
| May, 2003 | EIR | Gemini Pharmaceuticals, Inc. dba Plus Pharma - EIR, 2003-05-30 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more